Date Posted: Apr 13, 2018
Application Deadline: Open Until Filled
- Mayo Clinic
- Location: Rochester, MN
- Job Number: 7050776
- Posting Date: Apr 13, 2018
- Application Deadline:
Open Until Filled
Postdoctoral positions in Dr. Keith Robertson’s laboratory are available immediately for highly motivated individuals interested in studying epigenetic regulation of cancer and development as part of the Center for Individualized Medicine (CIM) Epigenomics Program at the Mayo Clinic in Rochester, MN. More information is available at these sites.
CIM Epigenomics Program:
The Robertson laboratory integrates basic and translational studies to understand how DNA methylation and DNA hydroxymethylation are targeted during development and how they become deregulated and contribute to human diseases like cancer. Specific research areas include application of epigenomics methods to decipher DNA methylation/hydroxymethylation contributions to disease, environmental factor-epigenome interactions, and mechanistic studies of the TETs and DNMTs. Tumors of the liver, kidney and brain are main cancer focus areas.
Recent publications are located here:
Mayo Clinic's unique culture of collaboration and teamwork create an ideal environment for those interested in careers in translational biomedical research. The more than 800 faculty actively engaged in research are supported by a research budget of nearly $700 million, extensive core facilities, and the Mayo Graduate and Medical Schools.
The applicant should have a Ph.D. and/or M.D. degree and experience in basic molecular biology techniques. Additional experience in any of the following areas is desirable: epigenetics methods, protein biochemistry, or next-gen sequencing data analysis. Mastery of other advanced research techniques will be accepted as evidence of an ability to learn the skills needed in this laboratory. Interested individuals should email their CV, brief description of past research experience and future goals, and contact information for three references to:
Keith D. Robertson, Ph.D.